Latest filing published 09 Sept 2008 for Ernexa Therapeutics Inc., €1,788.
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -65.9%Entry US$682,500.00 · Close at T+365 US$232,500.00
- -22.2%Entry US$877,500.00 · Close at T+365 US$682,500.00
- -31.1%Entry US$1,230,000.00 · Close at T+365 US$847,500.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert B. Clasen: trading record in brief
All filings by Robert B. Clasen on record concern Ernexa Therapeutics Inc. Over a trading history stretching from 16 May 2006 to 9 September 2008, the count stands at 4 filings.
Every open-market trade on record is a purchase: 3 purchases worth €29k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.
A typical purchase (the median) is worth €9,199. Ninety days after publication, 3 purchases show a median change of -17.6%, with the price up in 33% of them. Past outcomes like these are no guarantee of what comes next.
On 9 September 2008 came the latest disclosure, a share grant for €1,788 in Ernexa Therapeutics Inc. The latest purchase dates back some time: it was published 7,025 days ago, on 16 August 2007. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert B. Clasen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.25Common StockSEC:0001181431-08-052266:0
- 10,000 shares@ US$0.9031Common StockSEC:0000898430-07-003010:0Canonical exit: 13 Nov 2007 (T+90)
- 10,000 shares@ US$1.18Common StockSEC:0001181431-06-048821:0Canonical exit: 16 Nov 2006 (T+90)
- 10,000 shares@ US$1.61Common Stock, $.005 par valueSEC:0001187229-06-000001:0Canonical exit: 14 Aug 2006 (T+90)
4 of 4 declarations
